INOVIO Announces Survival Results for INO-5401 + INO-9012 in Combination with Libtayo® (cemiplimab) in Patients with Newly Diagnosed GBM at ASCO 2022 @ASCO
$ino GBM Glioblastoma
55% of MGMT methylated subjects remain alive at a median of 32.5 month https://t.co/5bnSw3agCy
Alcohol death rates in Europe. Apparently very low in cultures where drunkenness is frowned upon and where alcohol is only consumed in company of others and served alongside meals. Spain and Italy for example. Source: https://t.co/3nJTWpcobj
Thirty five generic drugmakers around the world will make cheap versions of Pfizer Inc's highly effective COVID-19 oral antiviral Paxlovid to supply the treatment in 95 poorer countries, the U.N.-backed Medicines Patent Pool (MPP) said on Thursday. https://t.co/cenCLfluQl
Can mRNA technology be used beyond vaccines?
I talked with #Moderna doctors about the use of mRNA technologies to have the body make Vascular Endothelial Growth Factor (VEGF) which in turn may promote the growth of new blood vessels in patients with heart disease.
#SARSCoV2 is a novel virus that damages the brain and heart.
This is 1 reason why many people encourage more protection like high filtration masking in addition to vaccines.
DOSE of exposure to the virus matters.
There is so much we still don't know about long term outcomes.
Heart-disease risk soars after Covid — even with a mild case. Massive study shows a long-term, substantial rise in risk of cardiovascular disease, including heart attack and stroke, after a SARSCoV2 infection https://t.co/qGLd1aX6XJ
Commenting on the work of Mortensen et al. CAC & Plaque absence associated with low CVD risk in people with hypercholesterolemia ! Expanding previous evidence and helping the choice of adequate therapies. #prevention#cholesterol#POWEROFZERO https://t.co/BHbQ2W2iqo
Astronomers say they have seen signs that two giant black holes are gearing up for a cataclysmic merger.
The event, if it happens, would be momentous for astronomy. https://t.co/BtafRZ39Nt
How well can Omicron evade immunity from COVID vaccines? https://t.co/7uYuj1yfnp People who become infected with SARS-CoV-2 after three doses of COVID-19 vaccine are more likely to have the Omicron than Delta, owing to Omicron’s ability to evade the immune system.
#Omicron I The WHO's @mvankerkhove said with the level of intensity of spread, the possibility that we will have other variants is really high. https://t.co/wMXInTzCFQ
A new study shows HIV can evolve to be more severe and contagious. It serves as a reminder in the age of COVID that viruses don't always weaken over time.
"We should never underestimate the potential for viral evolution," says Joel Wertheim of UCSD. https://t.co/RqvzZ8nNhI
@DrEricDing It is worrisome. However, BA.2 is no more severe, immune evasive, or associated with increased hospitalizations.
BA.2 is more rapidly multiplying and outpacing BA.1.
Recent study showed BA.1 infection protects against BA.2 infection
https://t.co/2qcl3sQ9Nn